Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01458990 · ClinicalTrials.gov registry record · NA

Proton Pump Inhibitors and Dysbiosis in Cirrhosis

A NA study, sponsored by Hunter Holmes Mcguire Veteran Affairs Medical Center.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT01458990: Completed NA study, sponsored by Hunter Holmes Mcguire Veteran Affairs Medical Center.

NCT01458990 is a NA study that has completed, run by Hunter Holmes Mcguire Veteran Affairs Medical Center. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01458990, a NA study, has completed, sponsored by Hunter Holmes Mcguire Veteran Affairs Medical Center.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

The purpose of this study is to find out whether the use of medications that suppress acid in your stomach can change the composition of your bowel bacteria.

Primary Outcome

Analysis at baseline will be compared to that at 2 weeks using Multitagged sequencing. Number of patients with overgrowth of oral microbiota in their stool after PPI therapy withdrawal or initiation were specifically analyzed.

Interventions

  • DRUG Omeprazole

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2011-10
Est. Completion 2018-02
Phase NA

What the finished NCT01458990 record still lists

NCT01458990 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which Omeprazole is the first listed.

NCT01458990 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01458990 about?

NCT01458990 is a clinical study titled "Proton Pump Inhibitors and Dysbiosis in Cirrhosis". The purpose of this study is to find out whether the use of medications that suppress acid in your stomach can change the composition of your bowel bacteria.

What is the current status of trial NCT01458990?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2011-10. Estimated completion is 2018-02.

What interventions are being tested in trial NCT01458990?

The interventions under investigation include: Omeprazole (DRUG).

Who is sponsoring clinical trial NCT01458990?

This trial is sponsored by Hunter Holmes Mcguire Veteran Affairs Medical Center, which has 27 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01458990's enrollment target sits among peer trials

60 1164th of 2000 higher than 745 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01458990, the US trial registry maintained by the National Library of Medicine. NCT01458990 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.